Use of Closed System Transfer Devices (CSTDs) with ProteinBased Therapeutic Drugs-A Non-Solution for a Non-Problem?JOURNAL OF PHARMACEUTICAL SCIENCESIF3.82024-02-012PRE
Correction: End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based Therapeutics(vol 25, 6, 2023)AAPS JOURNALIF3.72023-01-111OA
End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based TherapeuticsAAPS JOURNALIF3.72022-12-058PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向